Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
Federico VerdeIlaria MiloneIlaria BulgarelliSilvia PeverelliClaudia ColombritaAlessio MaranzanoNarghes CalcagnoNicola TicozziGiovanni Battista PeregoGianfranco ParatiErminio TorresaniAntonia RattiVincenzo SilaniPublished in: Journal of neurology (2022)
We provide neurochemical evidence of subclinical axonal damage in Covid-19 also in the absence of major neurological manifestations. This is apparently not fully explained by hypoxic injury; rather, systemic inflammation might promote this damage. However, a direct neurotoxic effect of SARS-CoV-2 cannot be excluded.